%0 Journal Article
%T Efficacy of Manual Lymphatic Drainage for Breast Cancer-Related Lymphedema
%A Na Li
%A Qi Wu
%A Feng Liu
%A Liping Zhang
%A Lijuan Zhang
%A Qiaoling Zhong
%A Huizhen Zhang
%J Advances in Breast Cancer Research
%P 120-127
%@ 2168-1597
%D 2022
%I Scientific Research Publishing
%R 10.4236/abcr.2022.112010
%X <strong>Purpose:</strong> <span><span><span style=\"font-family:;\" \"=\"\"><span style=\"font-family:Verdana;\">The effect of manual lymphatic drainage in patients with breast cancer is
controversial. The purpose of this study is to evaluate the role of manual
lymphatic drainage (MLD) in breast cancer-related lymphedema treatment. </span><b><span style=\"font-family:Verdana;\">Methods: </span></b><span style=\"font-family:Verdana;\">The electronic databases of EMBASE, PubMed, Web of S</span><span style=\"font-family:Verdana;\">cience, and The Cochrane Library were searched to find English articles
on MLD which </span></span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">were </span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">published before January 2020.
After two evaluators selected the studies and independently evaluated
literature quality, meta-analysis was carried out with RevMan 5.3 software. The
outcome index o</span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">f lymphedema treatment change</span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">d</span></span></span><span><span><span style=\"font-family:;\" \"=\"\"><span style=\"font-family:Verdana;\"> in edema
volume. </span><b><span style=\"font-family:Verdana;\">Results: </span></b><span style=\"font-family:Verdana;\">The study included</span><b> </b><span style=\"font-family:Verdana;\">six RCTs of 364 patients and
the meta-analysis showed no significant difference in the effect of MLD for
BCRL compared with other treatments (mean difference, 3.76; 95% confidence
interval, -35.09 to 42.62; Z, </span></span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">0</span></span></span><span><span><span style=\"font-family:;\" \"=\"\"><span style=\"font-family:Verdana;\">.19; </span><i><span style=\"font-family:Verdana;\">p</span></i><span style=\"font-family:Verdana;\"> = </span></span></span></span><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\"><span style=\"font-family:Verdana;\">0</span></span></span><span><span><span style=\"font-family:;\" \"=\"\"><span style=\"font-family:Verdana;\">.850). </span><b><span style=\"font-family:Verdana;\">Conclusion: </span></b><span
%K Manual Lymphatic Drainage
%K Meta-Analysis
%K Breast Cancer Lymphedema
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=116586